Immunome (IMNM) Assets Average: 2023-2025
Historic Assets Average for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $297.8 million.
- Immunome's Assets Average rose 7.69% to $297.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $297.8 million, marking a year-over-year increase of 7.69%. This contributed to the annual value of $194.4 million for FY2024, which is N/A change from last year.
- Latest data reveals that Immunome reported Assets Average of $297.8 million as of Q3 2025, which was down 6.78% from $319.5 million recorded in Q2 2025.
- In the past 5 years, Immunome's Assets Average ranged from a high of $319.5 million in Q2 2025 and a low of $44.8 million during Q2 2023.
- Over the past 3 years, Immunome's median Assets Average value was $262.6 million (recorded in 2024), while the average stood at $220.9 million.
- Data for Immunome's Assets Average shows a peak YoY soared of 587.86% (in 2024) over the last 5 years.
- Immunome's Assets Average (Quarterly) stood at $120.9 million in 2023, then spiked by 105.68% to $248.6 million in 2024, then rose by 7.69% to $297.8 million in 2025.
- Its Assets Average stands at $297.8 million for Q3 2025, versus $319.5 million for Q2 2025 and $291.5 million for Q1 2025.